Does GLICLAZIDE Cause Mobility decreased? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Mobility decreased have been filed in association with GLICLAZIDE. This represents 1.6% of all adverse event reports for GLICLAZIDE.
94
Reports of Mobility decreased with GLICLAZIDE
1.6%
of all GLICLAZIDE reports
0
Deaths
80
Hospitalizations
How Dangerous Is Mobility decreased From GLICLAZIDE?
Of the 94 reports, 80 (85.1%) required hospitalization, and 3 (3.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLICLAZIDE. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does GLICLAZIDE Cause?
Hypoglycaemia (756)
Nausea (596)
Acute kidney injury (553)
Drug ineffective (507)
Fall (415)
Dyspnoea (400)
Vomiting (385)
Lactic acidosis (373)
Malaise (360)
Hypertension (351)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GLICLAZIDE Alternatives Have Lower Mobility decreased Risk?
GLICLAZIDE vs GLIMEPIRIDE
GLICLAZIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLICLAZIDE vs GLIPIZIDE
GLICLAZIDE vs GLIVEC
GLICLAZIDE vs GLOFITAMAB